The FDA Dec. 18 issued final guidance on its Breakthrough Devices Program, a voluntary program for new medical devices and device-led combination products that provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. The program is designed to speed such innovative devices to market through more interactive engageme... Read More